NASDAQ · Biotechnology

Immix Biopharma, Inc. (IMMX) Stock

$9.46 +1.83% NASDAQ: IMMX Healthcare

Valuation

MetricValue
Price$9.46
Market Cap$514.64M
P/E Ratio-11.00
P/B Ratio2.70
P/S Ratio0.00
EPS (TTM)$-0.89
52-Week High$15.10
52-Week Low$1.99
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-38.44%
ROA-16.69%
ROCE-18.20%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.01
Current Ratio10.10

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-1.0M$-8.0M$-16.0M$-23.0M$-30.0M
Net Profit$-24.0M$-8.0M$-15.0M$-22.0M$-29.0M
EPS$-6.64$-0.59$-0.89$-0.76$-0.89
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$18.0M$15.0M$20.0M$23.0M$105.0M
Total Liabilities$0$2.0M$4.0M$10.0M$11.0M
Cash$18.0M$13.0M$18.0M$18.0M$94.0M
Borrowings$0$0$0$1.0M$1.0M

Latest News

Wall Street Analysts Think Immix Biopharma (IMMX) Could Surge 113.58%: Read This Before Placing a Bet Zacks · Jun 18, 2026 BofA Initiates Immix Biopharma at Buy With $27 Price Target MT Newswires · Jun 18, 2026 Exploring 3 High Growth Tech Stocks in the US Market Simply Wall St. · Jun 9, 2026 Wall Street Analysts See a 120.59% Upside in Immix Biopharma (IMMX): Can the Stock Really Move This High? Zacks · May 27, 2026 Immix Biopharma Announces Closing of $150 Million Underwritten Offering of Common Stock GlobeNewswire · May 22, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-2.0M$-7.0M$-11.0M$-15.0M$-24.0M
Investing Cash Flow$0$0$0$-2.0M$-8.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$17.0M$-4.0M$4.0M$0$76.0M
Free Cash Flow$-2.0M$-7.0M$-11.0M$-16.0M$-25.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.82
EV / EBITDA-7.50
FCF Yield-7.42%
Quick Ratio25.13
Interest Coverage0.00
Return 1Y203.45%
Return 3Y325.12%
Return 5Y—

Ownership

Insiders Held17.56%
Institutions Held45.30%
Institutions Float Held54.95%
Institutional HolderSharesReport Date
Janus Henderson Group PLC4,802,0022026-03-31
Saturn V Capital Management LP3,693,5852026-03-31
Eventide Asset Management LLC2,549,0192026-03-31
Vanguard Capital Management LLC1,787,9942026-03-31
Millennium Management Llc1,750,2002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ABVXAbivax S.A. $136.94 +1.50% -24.37 $10.06B 0.00%
CLDXCelldex Therapeutics, Inc. $29.89 +2.01% -7.26 $1.99B 0.00%
CRDFCardiff Oncology, Inc. $1.08 +1.89% -1.87 $83.24M 0.00%
CTMXCytomX Therapeutics, Inc. $2.57 +4.05% -5.69 $559.50M 0.00%
IMMPImmutep Limited $0.44 +0.90% -0.94 $64.36M 0.00%

About Immix Biopharma, Inc.

Immix Biopharma, Inc. is led by CEO Ilya Rachman, employs 18 people, headquartered in US, publicly traded since 2021.

Immix Biopharma, Inc. (IMMX) stock trades at $9.46 with a market capitalization of $514.64M. The stock is valued at a price-to-earnings (P/E) ratio of -11.00, price-to-book of 2.70, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $1.99 and $15.10, and currently trades 37.4% below its 52-week high.

On profitability, Immix Biopharma, Inc. generates a return on equity (ROE) of -38.44%, return on capital employed of -18.20%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides